- Filed
- Jun 27, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2023 · May 12, 2023 | 129.68M sh |
| Shares Diluted | Q1 2023 · Mar 31, 2023 | 51.48M sh |
| Shares Diluted | Q1 2023 · Mar 31, 2022 | 26.64M sh |
| Operating Cash Flow restated | Q1 2023 · Mar 31, 2023 | $66.47K |
| Operating Cash Flow restated | Q1 2023 · Mar 31, 2022 | −$610.62K |
| Cash And Equivalents | Q1 2023 · Mar 31, 2023 | $115.5K |
| Cash And Equivalents | Q1 2023 · Dec 31, 2022 | $35.25K |
| Stockholders Equity restated | Q1 2023 · Mar 31, 2023 | −$1.86M |
| Stockholders Equity restated | Q1 2023 · Dec 31, 2022 | −$2.07M |
| Total Liabilities restated | Q1 2023 · Mar 31, 2023 | $1.98M |
| Total Liabilities | Q1 2023 · Dec 31, 2022 | $2.11M |
| Total Assets restated | Q1 2023 · Mar 31, 2023 | $115.5K |
| Total Assets restated | Q1 2023 · Dec 31, 2022 | $35.25K |
| Eps Diluted | Q1 2023 · Mar 31, 2023 | −$0.04 |
| Eps Diluted | Q1 2023 · Mar 31, 2022 | −$0.05 |
| Eps Basic | Q1 2023 · Mar 31, 2023 | −$0.04 |
| Eps Basic | Q1 2023 · Mar 31, 2022 | −$0.05 |
| Rd Expense | Q1 2023 · Mar 31, 2023 | $55K |
| Rd Expense | Q1 2023 · Mar 31, 2022 | $1.09M |
| Net Income restated | Q1 2023 · Mar 31, 2023 | −$1.92M |
| Operating Income restated | Q1 2023 · Mar 31, 2023 | −$1.92M |
| Operating Income | Q1 2023 · Mar 31, 2022 | −$1.39M |
| Gross Profit | Q1 2023 · Mar 31, 2023 | $33.27K |
| Gross Profit | Q1 2023 · Mar 31, 2022 | $1.07M |
| Cost Of Revenue | Q1 2023 · Mar 31, 2023 | $38.65K |
| Cost Of Revenue | Q1 2023 · Mar 31, 2022 | $2.24M |
| Revenue | Q1 2023 · Mar 31, 2023 | $71.92K |
| Revenue | Q1 2023 · Mar 31, 2022 | $3.31M |